摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-Chloro-phenyl)-6,7-dimethyl-4-oxo-4H-chromene-8-carbonitrile | 129697-10-5

中文名称
——
中文别名
——
英文名称
2-(2-Chloro-phenyl)-6,7-dimethyl-4-oxo-4H-chromene-8-carbonitrile
英文别名
2-(2-Chlorophenyl)-6,7-dimethyl-4-oxo-4H-chromene-8-carbonitrile;2-(2-chlorophenyl)-6,7-dimethyl-4-oxochromene-8-carbonitrile
2-(2-Chloro-phenyl)-6,7-dimethyl-4-oxo-4H-chromene-8-carbonitrile化学式
CAS
129697-10-5
化学式
C18H12ClNO2
mdl
——
分子量
309.752
InChiKey
YFPIIBODDHAOTJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    50.1
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Cell death triggered by synthetic flavonoids in human leukemia cells is amplified by the inhibition of extracellular signal-regulated kinase signaling
    作者:Sara Rubio、Francisco León、José Quintana、Stephen Cutler、Francisco Estévez
    DOI:10.1016/j.ejmech.2012.07.028
    日期:2012.9
    A new class of methyl esters of flavonoids, with different substituents on the B ring were synthesized and evaluated for their antiproliferative activity against the human leukemia cell line HL-60. The presence of either a methyl group (1f) or a chlorine atom (1o) at position 2' of the B ring played an important role in affecting antiproliferative activity. The cytotoxic effects of these compounds were accompanied by the concentration- and time-dependent appearance of DNA- and nuclear-fragmentation, increase in the percentage of sub-G(1) cells, and processing of multiple caspases and poly(ADP-ribose)polymerase cleavage. Pretreatment of cells with the specific mitogen-activated extracellular kinases (MEK) 1/2 inhibitor PD98059, together with if and 1o, resulted in an important enhancement of cell death, which might have clinical implications for the use of both compounds in combination with MEK 1/2 inhibitors as potential therapeutic agents. (C) 2012 Elsevier Masson SAS. All rights reserved.
查看更多